Label Changes for:

Relpax (eletriptan) Tablets

April 2011

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011

 

ADVERSE REACTIONS

Other Events Observed During Postmarketing Use
  • ...vomiting...
Hide
(web5)